Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 643 entries
Sorted by: Best Match Show Resources per page
[On childbirth and child rearing. 9. The pregnant woman and her diet].

Josanpu zasshi = The Japanese journal for midwife

Miyasato K, Sakakura K, Suganuma H, Kamata H, Suemitsu H.
PMID: 3854880
Josanpu Zasshi. 1985 Dec;39(12):1065-8.

No abstract available.

Cite
Miyasato K, Sakakura K, Suganuma H, et al. [On childbirth and child rearing. 9. The pregnant woman and her diet]. Josanpu Zasshi. 1985;39(12):1065-8
Miyasato, K., Sakakura, K., Suganuma, H., Kamata, H., & Suemitsu, H. (1985). [On childbirth and child rearing. 9. The pregnant woman and her diet]. Josanpu zasshi = The Japanese journal for midwife, 39(12), 1065-8.
Miyasato, K, et al. "[On childbirth and child rearing. 9. The pregnant woman and her diet]." Josanpu zasshi = The Japanese journal for midwife vol. 39,12 (1985): 1065-8.
Miyasato K, Sakakura K, Suganuma H, Kamata H, Suemitsu H. [On childbirth and child rearing. 9. The pregnant woman and her diet]. Josanpu Zasshi. 1985 Dec;39(12):1065-8. Japanese. PMID: 3854880.
Copy Download .nbib Format: NLM
[Methods of nursing care in internal medicine].

Kango kyoshitsu. [Nursing classroom]

Kawada H.
PMID: 5186578
Kango Kyoshitsu. 1967 Dec;11(13):12-5.

No abstract available.

Cite
Kawada H. [Methods of nursing care in internal medicine]. Kango Kyoshitsu. 1967;11(13):12-5
Kawada, H. (1967). [Methods of nursing care in internal medicine]. Kango kyoshitsu. [Nursing classroom], 11(13), 12-5.
Kawada, H. "[Methods of nursing care in internal medicine]." Kango kyoshitsu. [Nursing classroom] vol. 11,13 (1967): 12-5.
Kawada H. [Methods of nursing care in internal medicine]. Kango Kyoshitsu. 1967 Dec;11(13):12-5. Japanese. PMID: 5186578.
Copy Download .nbib Format: NLM
Rationale, Design, and Baseline Characteristics of the Utopia Trial for Preventing Diabetic Atherosclerosis Using an SGLT2 Inhibitor: A Prospective, Randomized, Open-Label, Parallel-Group Comparative Study.

Diabetes therapy : research, treatment and education of diabetes and related disorders

Katakami N, Mita T, Yoshii H, Shiraiwa T, Yasuda T, Okada Y, Umayahara Y, Kaneto H, Osonoi T, Yamamoto T, Kuribayashi N, Maeda K, Yokoyama H, Kosugi K, Ohtoshi K, Hayashi I, Sumitani S, Tsugawa M, Ohashi M, Taki H, Nakamura T, Kawashima S, Sato Y, Watada H, Shimomura I.
PMID: 28864997
Diabetes Ther. 2017 Oct;8(5):999-1013. doi: 10.1007/s13300-017-0292-1. Epub 2017 Sep 01.

INTRODUCTION: Sodium-glucose co-transporter-2 (SGLT2) inhibitors are anti-diabetic agents that improve glycemic control with a low risk of hypoglycemia and ameliorate a variety of cardiovascular risk factors. The aim of the ongoing study described herein is to investigate the preventive...

Cite
Katakami N, Mita T, Yoshii H, et al. Rationale, Design, and Baseline Characteristics of the Utopia Trial for Preventing Diabetic Atherosclerosis Using an SGLT2 Inhibitor: A Prospective, Randomized, Open-Label, Parallel-Group Comparative Study. Diabetes Ther. 2017;8(5):999-1013doi: 10.1007/s13300-017-0292-1.
Katakami, N., Mita, T., Yoshii, H., Shiraiwa, T., Yasuda, T., Okada, Y., Umayahara, Y., Kaneto, H., Osonoi, T., Yamamoto, T., Kuribayashi, N., Maeda, K., Yokoyama, H., Kosugi, K., Ohtoshi, K., Hayashi, I., Sumitani, S., Tsugawa, M., Ohashi, M., Taki, H., Nakamura, T., Kawashima, S., Sato, Y., Watada, H., Shimomura, I. (2017). Rationale, Design, and Baseline Characteristics of the Utopia Trial for Preventing Diabetic Atherosclerosis Using an SGLT2 Inhibitor: A Prospective, Randomized, Open-Label, Parallel-Group Comparative Study. Diabetes therapy : research, treatment and education of diabetes and related disorders, 8(5), 999-1013. https://doi.org/10.1007/s13300-017-0292-1
Katakami, Naoto, et al. "Rationale, Design, and Baseline Characteristics of the Utopia Trial for Preventing Diabetic Atherosclerosis Using an SGLT2 Inhibitor: A Prospective, Randomized, Open-Label, Parallel-Group Comparative Study." Diabetes therapy : research, treatment and education of diabetes and related disorders vol. 8,5 (2017): 999-1013. doi: https://doi.org/10.1007/s13300-017-0292-1
Katakami N, Mita T, Yoshii H, Shiraiwa T, Yasuda T, Okada Y, Umayahara Y, Kaneto H, Osonoi T, Yamamoto T, Kuribayashi N, Maeda K, Yokoyama H, Kosugi K, Ohtoshi K, Hayashi I, Sumitani S, Tsugawa M, Ohashi M, Taki H, Nakamura T, Kawashima S, Sato Y, Watada H, Shimomura I. Rationale, Design, and Baseline Characteristics of the Utopia Trial for Preventing Diabetic Atherosclerosis Using an SGLT2 Inhibitor: A Prospective, Randomized, Open-Label, Parallel-Group Comparative Study. Diabetes Ther. 2017 Oct;8(5):999-1013. doi: 10.1007/s13300-017-0292-1. Epub 2017 Sep 01. PMID: 28864997; PMCID: PMC5630549.
Copy Download .nbib Format: NLM
Temporal lobe epilepsy associated with GAD autoimmunity.

Acta diabetologica

Obata A, Kutoku Y, Sunada Y, Okauchi S, Kimura T, Hirukawa H, Tanabe A, Kinoshita T, Kohara K, Tatsumi F, Shimoda M, Kamei S, Nakanishi S, Mune T, Kaku K, Kaneto H.
PMID: 27638303
Acta Diabetol. 2017 Mar;54(3):321-323. doi: 10.1007/s00592-016-0910-9. Epub 2016 Sep 08.

No abstract available.

Cite
Obata A, Kutoku Y, Sunada Y, et al. Temporal lobe epilepsy associated with GAD autoimmunity. Acta Diabetol. 2016;54(3):321-323doi: 10.1007/s00592-016-0910-9.
Obata, A., Kutoku, Y., Sunada, Y., Okauchi, S., Kimura, T., Hirukawa, H., Tanabe, A., Kinoshita, T., Kohara, K., Tatsumi, F., Shimoda, M., Kamei, S., Nakanishi, S., Mune, T., Kaku, K., & Kaneto, H. (2017). Temporal lobe epilepsy associated with GAD autoimmunity. Acta diabetologica, 54(3), 321-323. https://doi.org/10.1007/s00592-016-0910-9
Obata, Atsushi, et al. "Temporal lobe epilepsy associated with GAD autoimmunity." Acta diabetologica vol. 54,3 (2017): 321-323. doi: https://doi.org/10.1007/s00592-016-0910-9
Obata A, Kutoku Y, Sunada Y, Okauchi S, Kimura T, Hirukawa H, Tanabe A, Kinoshita T, Kohara K, Tatsumi F, Shimoda M, Kamei S, Nakanishi S, Mune T, Kaku K, Kaneto H. Temporal lobe epilepsy associated with GAD autoimmunity. Acta Diabetol. 2017 Mar;54(3):321-323. doi: 10.1007/s00592-016-0910-9. Epub 2016 Sep 08. PMID: 27638303; PMCID: PMC5329084.
Copy Download .nbib Format: NLM
Unexpectedly long intravenous and intracardiac extension of a small-sized pulmonary pleomorphic carcinoma.

Journal of thoracic disease

Ishii A, Kimura T, Moritani K, Cui D, Tanaka S, Kawano H, Ikeda E.
PMID: 25590004
J Thorac Dis. 2014 Dec;6(12):E259-63. doi: 10.3978/j.issn.2072-1439.2014.10.25.

Pleomorphic carcinoma of the lung is one of the uncommon histological types of lung cancers, which shows an aggressive behavior. Intravenous extension (not metastasis or direct invasion) of the tumor into the heart is a rare complication of lung...

Cite
Ishii A, Kimura T, Moritani K, et al. Unexpectedly long intravenous and intracardiac extension of a small-sized pulmonary pleomorphic carcinoma. J Thorac Dis. 2014;6(12):E259-63doi: 10.3978/j.issn.2072-1439.2014.10.25.
Ishii, A., Kimura, T., Moritani, K., Cui, D., Tanaka, S., Kawano, H., & Ikeda, E. (2014). Unexpectedly long intravenous and intracardiac extension of a small-sized pulmonary pleomorphic carcinoma. Journal of thoracic disease, 6(12), E259-63. https://doi.org/10.3978/j.issn.2072-1439.2014.10.25
Ishii, Aya, et al. "Unexpectedly long intravenous and intracardiac extension of a small-sized pulmonary pleomorphic carcinoma." Journal of thoracic disease vol. 6,12 (2014): E259-63. doi: https://doi.org/10.3978/j.issn.2072-1439.2014.10.25
Ishii A, Kimura T, Moritani K, Cui D, Tanaka S, Kawano H, Ikeda E. Unexpectedly long intravenous and intracardiac extension of a small-sized pulmonary pleomorphic carcinoma. J Thorac Dis. 2014 Dec;6(12):E259-63. doi: 10.3978/j.issn.2072-1439.2014.10.25. PMID: 25590004; PMCID: PMC4283330.
Copy Download .nbib Format: NLM
Structure, Function, Pharmacology, and Therapeutic Potential of the G Protein, Gα/q,11.

Frontiers in cardiovascular medicine

Kamato D, Thach L, Bernard R, Chan V, Zheng W, Kaur H, Brimble M, Osman N, Little PJ.
PMID: 26664886
Front Cardiovasc Med. 2015 Mar 24;2:14. doi: 10.3389/fcvm.2015.00014. eCollection 2015.

G protein coupled receptors (GPCRs) are one of the major classes of cell surface receptors and are associated with a group of G proteins consisting of three subunits termed alpha, beta, and gamma. G proteins are classified into four...

Cite
Kamato D, Thach L, Bernard R, et al. Structure, Function, Pharmacology, and Therapeutic Potential of the G Protein, Gα/q,11. Front Cardiovasc Med. 2015;2:14doi: 10.3389/fcvm.2015.00014.
Kamato, D., Thach, L., Bernard, R., Chan, V., Zheng, W., Kaur, H., Brimble, M., Osman, N., & Little, P. J. (2015). Structure, Function, Pharmacology, and Therapeutic Potential of the G Protein, Gα/q,11. Frontiers in cardiovascular medicine, 214. https://doi.org/10.3389/fcvm.2015.00014
Kamato, Danielle, et al. "Structure, Function, Pharmacology, and Therapeutic Potential of the G Protein, Gα/q,11." Frontiers in cardiovascular medicine vol. 2 (2015): 14. doi: https://doi.org/10.3389/fcvm.2015.00014
Kamato D, Thach L, Bernard R, Chan V, Zheng W, Kaur H, Brimble M, Osman N, Little PJ. Structure, Function, Pharmacology, and Therapeutic Potential of the G Protein, Gα/q,11. Front Cardiovasc Med. 2015 Mar 24;2:14. doi: 10.3389/fcvm.2015.00014. eCollection 2015. PMID: 26664886; PMCID: PMC4671355.
Copy Download .nbib Format: NLM
Angiotensin II suppresses osteoblastic differentiation and mineralized nodule formation via AT1 receptor in ROS17/2.8 cells.

Archives of medical science : AMS

Nakai K, Kawato T, Morita T, Yamazaki Y, Tanaka H, Tonogi M, Oki H, Maeno M.
PMID: 26170858
Arch Med Sci. 2015 Jun 19;11(3):628-37. doi: 10.5114/aoms.2015.52369.

INTRODUCTION: Angiotensin II (Ang II) not only regulates systemic blood pressure through a vasoconstrictive effect, but also promotes bone resorption. We recently reported that Ang II (10(-6) M) stimulated the production of matrix metalloproteinases via the AT1 receptor in...

Cite
Nakai K, Kawato T, Morita T, et al. Angiotensin II suppresses osteoblastic differentiation and mineralized nodule formation via AT1 receptor in ROS17/2.8 cells. Arch Med Sci. 2015;11(3):628-37doi: 10.5114/aoms.2015.52369.
Nakai, K., Kawato, T., Morita, T., Yamazaki, Y., Tanaka, H., Tonogi, M., Oki, H., & Maeno, M. (2015). Angiotensin II suppresses osteoblastic differentiation and mineralized nodule formation via AT1 receptor in ROS17/2.8 cells. Archives of medical science : AMS, 11(3), 628-37. https://doi.org/10.5114/aoms.2015.52369
Nakai, Kumiko, et al. "Angiotensin II suppresses osteoblastic differentiation and mineralized nodule formation via AT1 receptor in ROS17/2.8 cells." Archives of medical science : AMS vol. 11,3 (2015): 628-37. doi: https://doi.org/10.5114/aoms.2015.52369
Nakai K, Kawato T, Morita T, Yamazaki Y, Tanaka H, Tonogi M, Oki H, Maeno M. Angiotensin II suppresses osteoblastic differentiation and mineralized nodule formation via AT1 receptor in ROS17/2.8 cells. Arch Med Sci. 2015 Jun 19;11(3):628-37. doi: 10.5114/aoms.2015.52369. PMID: 26170858; PMCID: PMC4495158.
Copy Download .nbib Format: NLM
Upside-Down and Inside-Out Signs in Uterine Inversion.

Journal of clinical medicine research

Kawano H, Hasegawa J, Nakamura M, Maruyama D, Arakaki T, Ono A, Miyake Y, Sekizawa A.
PMID: 27298665
J Clin Med Res. 2016 Jul;8(7):548-9. doi: 10.14740/jocmr2538w. Epub 2016 May 29.

Uterine inversion is a rare condition that is accompanied by massive hemorrhaging and shock, resulting in a maternal emergency. The diagnosis of uterine inversion is often difficult due to massive postpartum hemorrhaging. Ultrasonography is useful for the diagnosis in...

Cite
Kawano H, Hasegawa J, Nakamura M, et al. Upside-Down and Inside-Out Signs in Uterine Inversion. J Clin Med Res. 2016;8(7):548-9doi: 10.14740/jocmr2538w.
Kawano, H., Hasegawa, J., Nakamura, M., Maruyama, D., Arakaki, T., Ono, A., Miyake, Y., & Sekizawa, A. (2016). Upside-Down and Inside-Out Signs in Uterine Inversion. Journal of clinical medicine research, 8(7), 548-9. https://doi.org/10.14740/jocmr2538w
Kawano, Haruka, et al. "Upside-Down and Inside-Out Signs in Uterine Inversion." Journal of clinical medicine research vol. 8,7 (2016): 548-9. doi: https://doi.org/10.14740/jocmr2538w
Kawano H, Hasegawa J, Nakamura M, Maruyama D, Arakaki T, Ono A, Miyake Y, Sekizawa A. Upside-Down and Inside-Out Signs in Uterine Inversion. J Clin Med Res. 2016 Jul;8(7):548-9. doi: 10.14740/jocmr2538w. Epub 2016 May 29. PMID: 27298665; PMCID: PMC4894026.
Copy Download .nbib Format: NLM
Case of aniridia with a heterozygous PAX6 mutation in which the glucagon response to arginine was evaluated.

Journal of diabetes investigation

Osawa S, Yasuda T, Kaneto H, Shimo N, Yamamoto Y, Kawamori D, Miyatsuka T, Matsuoka TA, Shimomura I.
PMID: 25621140
J Diabetes Investig. 2015 Jan;6(1):105-6. doi: 10.1111/jdi.12251. Epub 2015 Jan 01.

No abstract available.

Cite
Osawa S, Yasuda T, Kaneto H, et al. Case of aniridia with a heterozygous PAX6 mutation in which the glucagon response to arginine was evaluated. J Diabetes Investig. 2015;6(1):105-6doi: 10.1111/jdi.12251.
Osawa, S., Yasuda, T., Kaneto, H., Shimo, N., Yamamoto, Y., Kawamori, D., Miyatsuka, T., Matsuoka, T. A., & Shimomura, I. (2015). Case of aniridia with a heterozygous PAX6 mutation in which the glucagon response to arginine was evaluated. Journal of diabetes investigation, 6(1), 105-6. https://doi.org/10.1111/jdi.12251
Osawa, Saeko, et al. "Case of aniridia with a heterozygous PAX6 mutation in which the glucagon response to arginine was evaluated." Journal of diabetes investigation vol. 6,1 (2015): 105-6. doi: https://doi.org/10.1111/jdi.12251
Osawa S, Yasuda T, Kaneto H, Shimo N, Yamamoto Y, Kawamori D, Miyatsuka T, Matsuoka TA, Shimomura I. Case of aniridia with a heterozygous PAX6 mutation in which the glucagon response to arginine was evaluated. J Diabetes Investig. 2015 Jan;6(1):105-6. doi: 10.1111/jdi.12251. Epub 2015 Jan 01. PMID: 25621140; PMCID: PMC4296710.
Copy Download .nbib Format: NLM
Four hepatosplenic T-cell lymphoma cases of Japanese patients.

Leukemia research reports

Kawai H, Matsushita H, Ohmachi K, Kojima M, Machida S, Ogawa Y, Kawada H, Nakamura N, Ando K.
PMID: 26870659
Leuk Res Rep. 2015 Dec 15;5:3-6. doi: 10.1016/j.lrr.2015.12.001. eCollection 2016.

Hepatosplenic T-cell lymphoma (HSTCL), a rare type of γδ T-cell lymphoma, is characterized by hepatosplenomegaly and cytopenias. It is associated with immunodeficiency and its age of onset is reportedly between the 20s and 30s. We herein report 4 Japanese...

Cite
Kawai H, Matsushita H, Ohmachi K, et al. Four hepatosplenic T-cell lymphoma cases of Japanese patients. Leuk Res Rep. 2015;5:3-6doi: 10.1016/j.lrr.2015.12.001.
Kawai, H., Matsushita, H., Ohmachi, K., Kojima, M., Machida, S., Ogawa, Y., Kawada, H., Nakamura, N., & Ando, K. (2016). Four hepatosplenic T-cell lymphoma cases of Japanese patients. Leukemia research reports, 53-6. https://doi.org/10.1016/j.lrr.2015.12.001
Kawai, Hidetsugu, et al. "Four hepatosplenic T-cell lymphoma cases of Japanese patients." Leukemia research reports vol. 5 (2016): 3-6. doi: https://doi.org/10.1016/j.lrr.2015.12.001
Kawai H, Matsushita H, Ohmachi K, Kojima M, Machida S, Ogawa Y, Kawada H, Nakamura N, Ando K. Four hepatosplenic T-cell lymphoma cases of Japanese patients. Leuk Res Rep. 2015 Dec 15;5:3-6. doi: 10.1016/j.lrr.2015.12.001. eCollection 2016. PMID: 26870659; PMCID: PMC4711307.
Copy Download .nbib Format: NLM
Noninvasive cross-sectional observation of three-dimensional cell sheet-tissue-fabrication by optical coherence tomography.

Biochemistry and biophysics reports

Haraguchi Y, Shimizu T, Mizuuchi K, Kawata H, Kobayashi M, Hirai Y, Iwana SI.
PMID: 29124144
Biochem Biophys Rep. 2015 May 12;2:57-62. doi: 10.1016/j.bbrep.2015.05.001. eCollection 2015 Jul.

Cell sheet engineering allows investigators/clinicians to prepare cell-dense three-dimensional (3-D) tissues, and various clinical trials with these fabricated tissues have already been performed for regenerating damaged tissues. Cell sheets are easily manipulated and 3-D tissues can be rapidly fabricated...

Cite
Haraguchi Y, Shimizu T, Mizuuchi K, et al. Noninvasive cross-sectional observation of three-dimensional cell sheet-tissue-fabrication by optical coherence tomography. Biochem Biophys Rep. 2015;2:57-62doi: 10.1016/j.bbrep.2015.05.001.
Haraguchi, Y., Shimizu, T., Mizuuchi, K., Kawata, H., Kobayashi, M., Hirai, Y., & Iwana, S. I. (2015). Noninvasive cross-sectional observation of three-dimensional cell sheet-tissue-fabrication by optical coherence tomography. Biochemistry and biophysics reports, 257-62. https://doi.org/10.1016/j.bbrep.2015.05.001
Haraguchi, Yuji, et al. "Noninvasive cross-sectional observation of three-dimensional cell sheet-tissue-fabrication by optical coherence tomography." Biochemistry and biophysics reports vol. 2 (2015): 57-62. doi: https://doi.org/10.1016/j.bbrep.2015.05.001
Haraguchi Y, Shimizu T, Mizuuchi K, Kawata H, Kobayashi M, Hirai Y, Iwana SI. Noninvasive cross-sectional observation of three-dimensional cell sheet-tissue-fabrication by optical coherence tomography. Biochem Biophys Rep. 2015 May 12;2:57-62. doi: 10.1016/j.bbrep.2015.05.001. eCollection 2015 Jul. PMID: 29124144; PMCID: PMC5668641.
Copy Download .nbib Format: NLM
Regular insulin, rather than rapid-acting insulin, is a suitable choice for premeal bolus insulin in lean patients with type 2 diabetes mellitus.

Journal of diabetes investigation

Kuroda A, Kaneto H, Kawashima S, Sakamoto K, Takahara M, Shiraiwa T, Yasuda T, Katakami N, Matsuoka TA, Shimomura I, Matsuhisa M.
PMID: 24843634
J Diabetes Investig. 2013 Jan 29;4(1):78-81. doi: 10.1111/j.2040-1124.2012.00231.x. Epub 2012 Aug 21.

The aim of the present study was to compare the usefulness of premeal rapid-acting and regular insulin in type 2 diabetes patients. A total of 56 type 2 diabetic patients were investigated during hospitalization. Premeal rapid-acting insulin was applied...

Cite
Kuroda A, Kaneto H, Kawashima S, et al. Regular insulin, rather than rapid-acting insulin, is a suitable choice for premeal bolus insulin in lean patients with type 2 diabetes mellitus. J Diabetes Investig. 2012;4(1):78-81doi: 10.1111/j.2040-1124.2012.00231.x.
Kuroda, A., Kaneto, H., Kawashima, S., Sakamoto, K., Takahara, M., Shiraiwa, T., Yasuda, T., Katakami, N., Matsuoka, T. A., Shimomura, I., & Matsuhisa, M. (2013). Regular insulin, rather than rapid-acting insulin, is a suitable choice for premeal bolus insulin in lean patients with type 2 diabetes mellitus. Journal of diabetes investigation, 4(1), 78-81. https://doi.org/10.1111/j.2040-1124.2012.00231.x
Kuroda, Akio, et al. "Regular insulin, rather than rapid-acting insulin, is a suitable choice for premeal bolus insulin in lean patients with type 2 diabetes mellitus." Journal of diabetes investigation vol. 4,1 (2013): 78-81. doi: https://doi.org/10.1111/j.2040-1124.2012.00231.x
Kuroda A, Kaneto H, Kawashima S, Sakamoto K, Takahara M, Shiraiwa T, Yasuda T, Katakami N, Matsuoka TA, Shimomura I, Matsuhisa M. Regular insulin, rather than rapid-acting insulin, is a suitable choice for premeal bolus insulin in lean patients with type 2 diabetes mellitus. J Diabetes Investig. 2013 Jan 29;4(1):78-81. doi: 10.1111/j.2040-1124.2012.00231.x. Epub 2012 Aug 21. PMID: 24843634; PMCID: PMC4019291.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 643 entries